Revenue
$46.6B
Gross Margin
+56.8%
Operating Margin
+17.0%
Net Margin
+11.6%
Income statement waterfall for Abbott Laboratories (ABT) — TTM through Q2 2026
Net income: $5.43B
Margin breakdown for Abbott Laboratories (ABT) — TTM through Q2 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $46.6B | $46.6B |
| Cost of Revenue | -$20.1B | $26.5B |
| Gross Profit | $26.5B | $26.5B |
| Operating Expenses | -$18.5B | $7.93B |
| Operating Income | $7.93B | $7.93B |
| Other Income / Expense | -$421M | $7.51B |
| Pre-tax Income | $7.51B | $7.51B |
| Income Tax | -$2.09B | $5.43B |
| Net Income | $5.43B | $5.43B |
- Revenue$46.6B
- Cost of Revenue-$20.1B
- Gross Profit$26.5B
- Operating Expenses-$18.5B
- Operating Income$7.93B
- Other Income / Expense-$421M
- Pre-tax Income$7.51B
- Income Tax-$2.09B
- Net Income$5.43B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.44% TTM
- Dividend Profile2.47% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.